These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8537378)

  • 21. Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase.
    Tarbet EB; Stafforini DM; Elstad MR; Zimmerman GA; McIntyre TM; Prescott SM
    J Biol Chem; 1991 Sep; 266(25):16667-73. PubMed ID: 1653245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
    Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease).
    Pritchard PH; Chonn A; Yeung CC
    Blood; 1985 Dec; 66(6):1476-8. PubMed ID: 4063532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
    Stafforini DM; McIntyre TM; Carter ME; Prescott SM
    J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles.
    Marathe GK; Zimmerman GA; McIntyre TM
    J Biol Chem; 2003 Feb; 278(6):3937-47. PubMed ID: 12466264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.
    Liapikos TA; Antonopoulou S; Karabina SP; Tsoukatos DC; Demopoulos CA; Tselepis AD
    Biochim Biophys Acta; 1994 Jun; 1212(3):353-60. PubMed ID: 8199206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of platelet-activating factor in systemic lupus erythematosus.
    Tetta C; Bussolino F; Modena V; Montrucchio G; Segoloni G; Pescarmona G; Camussi G
    Int Arch Allergy Appl Immunol; 1990; 91(3):244-56. PubMed ID: 2354868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension.
    Satoh K; Imaizumi T; Kawamura Y; Yoshida H; Takamatsu S; Takamatsu M
    Prostaglandins; 1989 Jun; 37(6):673-82. PubMed ID: 2772220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human plasma platelet-activating factor acetylhydrolase. Purification and properties.
    Stafforini DM; Prescott SM; McIntyre TM
    J Biol Chem; 1987 Mar; 262(9):4223-30. PubMed ID: 3558407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase.
    Lee C; Sigari F; Segrado T; Hörkkö S; Hama S; Subbaiah PV; Miwa M; Navab M; Witztum JL; Reaven PD
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1437-46. PubMed ID: 10364074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats.
    Wójcicka G; Zaręba M; Warpas A; Jamroz-Wiśniewska A; Rusek M; Czechowska G; Bełtowski J
    Eur J Pharmacol; 2019 May; 850():180-189. PubMed ID: 30768981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAF-acetylhydrolase, predominantly present in LDL in healthy subjects, is associated with HDL in a patient with LDL deficiency.
    Surya II; Mommersteeg M; Erkelens DW; Akkerman JW
    J Lipid Mediat; 1991; 3(1):27-38. PubMed ID: 1768838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein.
    Napoli C; Triggiani M; Palumbo G; Condorelli M; Chiariello M; Ambrosio G
    Basic Res Cardiol; 1997 Apr; 92(2):96-105. PubMed ID: 9166989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the platelet-activating factor acetylhydrolase from human plasma by heterologous expression in Xenopus laevis oocytes.
    Yamada Y; Stafforini DM; Imaizumi T; Zimmerman GA; McIntyre TM; Prescott SM
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10320-4. PubMed ID: 7937948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.
    Tsimikas S; Tsironis LD; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2094-9. PubMed ID: 17626905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity.
    Tselepis AD; Elisaf M; Besis S; Karabina SA; Chapman MJ; Siamopoulou A
    Arthritis Rheum; 1999 Feb; 42(2):373-83. PubMed ID: 10025933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bovine seminal platelet-activating factor acetylhydrolase: association properties in seminal plasma and with lipoproteins.
    Soubeyrand S; Thérien I; Manjunath P
    Biochim Biophys Acta; 1998 Jun; 1392(2-3):176-84. PubMed ID: 9630618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
    Watson AD; Navab M; Hama SY; Sevanian A; Prescott SM; Stafforini DM; McIntyre TM; Du BN; Fogelman AM; Berliner JA
    J Clin Invest; 1995 Feb; 95(2):774-82. PubMed ID: 7860760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-activating factor acetylhydrolase in human seminal plasma.
    Letendre ED; Miron P; Roberts KD; Langlais J
    Fertil Steril; 1992 Jan; 57(1):193-8. PubMed ID: 1730316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phospholipase A(2) activity in non-glycated and glycated low density lipoproteins.
    Sakurai T; Yamamoto Y; Baba N; Nakano M
    Biochim Biophys Acta; 1996 May; 1301(1-2):85-9. PubMed ID: 8652655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.